Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-685-3 | CAS number: 68604-33-1 This substance is identified by SDA Substance Name: C14-C18 and C16-C18 unsaturated alkyl carboxylic acid ammonium salt and SDA Reporting Number: 04-006-01.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
No carcinogenic properties of the read across substance 9-octadecenoic acid were found.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Study duration:
- chronic
- Species:
- rat
- Quality of whole database:
- Reliable and well documented publication
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
DSD (67/548/EEC):
The available studies are considered reliable and suitable for classification purposes under 67/548/EEC. As a result the substance is not considered to be classified for carcinogenicity under Directive 67/548/EEC.
CLP/GHS (Regulation (EC) No 1272/2008):
The available experimental test data are reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. As a result the substance is not considered to be classified for carcinogenicity under Regulation (EC) No 1272/2008.
Additional information
No adequate animal data are available and no epidemiological studies investigating the carcinogenicity of the test (target) substance were identified. However, data from a structural analogue (read across substance) are available.
A publication (Hiasa, Y. 1984) is available in which a 108 weeks carcinogenicity study conducted with the analogue substance 9-octadecenoic acid (CAS 11-80-1) on male and female F344 rats is described. 150 male and female rats each were allocated to three dose groups.The control group received distilled drinking water, whereas the other two dose groups received 2.5 and 5 % of the read across substance administered via the drinking water (distilled water) for a duration of 108 weeks. The water consumption was determined twice a week, body weights were recorded every 2 or 4 weeks. At the end of the study, blood samples and urine samples were taken from 20 rats of each dosage group (10 males and 10 females). All surviving animals were killed and an autopsy was conducted on these animals as well as on those that were killed or found dead during the study, where possible. The following organs were examined for tumors and other lesions: brain, spinal cord, salivary, pituitary and thyroid (including parathyroid) glands, thymus, lungs (including the trachea), heart, oral cavity and tongue, oesophagus, stomach, duodenum. jejunum, ileum, caecum, colon, rectum, liver, pancreas, spleen, adrenal glands, lymph nodes, skin, subcutis, preputial/clitoral gland, ear duct, eyes, Harderian gIands, musculature, sternum, femur and nasal cavity. These organs and tissues and the found tumors were fixed and sectioned and afterwards stained with haematoxylin and eosin. As an outcome of these examinations, neither blood or urine analysis results nor tumour incidences differed significantly between the control and the test groups. An effect according organ weights was observed: In the 5 % dosage group, the mean liver weights of the male animals and the mean heart, pancreas and adrenals weights of the females were significantly lower than in the control group, and the thymus weight in the females was higher. From this publication it might be concluded that the LOEL concerning organ weights and the NOAEL for carcinogenicity for both male and females is 5 % in the drinking water /day.
In another publication (Clement Ip 1997) the results of several studies are summarized. As a conclusion on consuming an analogue substance (CAS 112 -80 -1) it is noted that there was no carcinogenic effect observed.
Justification for selection of
carcinogenicity via oral route endpoint: reliable and well
documented publication.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.